Dr. Mitchell E. Gross, MD

Dr. Gross practices at Saint John's Physician Partners in Santa Monica, California.

Dr. Gross' NPI, 1548298656, was assigned on June 29, 2006. Dr. Gross graduated from Baylor College Of Medicine in 1994. Dr. Gross holds California license A55762.

Dr. Gross' primary practice is Saint John's Physician Partners, at 901 Wilshire Blvd, Santa Monica, CA 90401 in Los Angeles County. The practice phone is (310) 582-7312.

Dr. Gross' primary practice is Saint John's Physician Partners in Santa Monica, California. The medical group on file is Saint John's Physician Partners. Dmand AI also links Dr. Gross to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gross practices, 2 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Gross' primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Gross is board certified in medical oncology by the American Board of Internal Medicine. Dr. Gross is licensed in California.

Dmand AI lists chronic anemia, fluid and electrolyte imbalances, lung cancer and prostate cancer among the conditions Dr. Gross treats.

CMS data shows 9,788 Medicare services from Dr. Gross across 18 procedure codes in 2024, for 137 Medicare patients. Medicare paid $252,209 for them. Every service was in an office.

CMS counts 137 Medicare patients who saw Dr. Gross in 2024. The largest group is 75 to 84, with 63 patients. 75% of them have cancer, and 75% have high cholesterol. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gross' median patient age at 73, with 9% women.

In 2024, Dr. Gross wrote 13 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $266 in total drug cost. In 2017, CMS named 11 claims across 1 drug.

Dr. Gross accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gross as offering telehealth.

Dmand AI links 10 papers to Dr. Gross, published from 2012 to 2015. 2012 was the busiest year, with 3. Dr. Gross' most frequent co-authors are David B. Agus, MD, Inderbir Singh Gill, MD and Osamu Ukimura, MD, PhD.

Dmand AI links Dr. Gross to 5 clinical trials, 3 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Prostatic Neoplasms, Prostatic Diseases and Neoplasm Metastasis. University of Southern California sponsors the most, 2.

CMS Open Payments shows 27 general payments to Dr. Gross from 6 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 70% of the total. Amgen Inc. paid the most, $7,592. It also lists 2 research payments totaling $270 from 2019 to 2020.

Dmand AI lists 8 awards for Dr. Gross, most recently Specialty Training Research Fellowship in 2002.

Dr. Gross graduated from Baylor College Of Medicine in 1994. Dr. Gross is a member of ASCO.

Dr. Gross is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.